Recently, a seminal study demonstrated that the elimination of senescent astrocytes, either through genetic or pharmacological means, prevented tau-dependent pathology and improved cognitive function in an AD mouse model [96]. The gene discussed is MAPT; the disease is Alzheimer disease.